Nanoform Finland Oyj (STO:NANOFS)
Sweden · Delayed Price · Currency is SEK 11.52
-0.12 (-1.03%)
At close: Aug 1, 2025
CTI BioPharma Market Cap
Nanoform Finland Oyj has a market cap or net worth of 1.02 billion as of August 1, 2025. Its market cap has decreased by -38.24% in one year.
Market Cap
1.02B
Enterprise Value
664.09M
Revenue
42.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
$11.52
Market Cap Chart
Since June 4, 2020, Nanoform Finland Oyj's market cap has decreased from 3.28B to 1.02B, a decrease of -69.00%. That is a compound annual growth rate of -20.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.02B | -25.14% |
| Dec 30, 2024 | 1.36B | -1.83% |
| Dec 29, 2023 | 1.39B | -50.39% |
| Dec 30, 2022 | 2.79B | -42.85% |
| Dec 30, 2021 | 4.89B | 2.95% |
| Dec 30, 2020 | 4.75B | 44.55% |
| Jun 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 102.35B |
| Sectra AB | 69.48B |
| Getinge AB | 53.34B |
| Camurus AB | 42.78B |
| Medicover AB | 41.67B |
| Asker Healthcare Group AB | 38.24B |
| Bonesupport Holding AB | 22.39B |
| AddLife AB | 21.08B |